Medpace Holdings Inc vs Mitsubishi UFJ Financial Group Inc. Common Stock — how do they compare? Medpace Holdings Inc trades at $615.8 (market cap $16.82B), while Mitsubishi UFJ Financial Group Inc. Common Stock trades at $22.37 (market cap $249.48B). The key difference: Mitsubishi UFJ Financial Group Inc. Common Stock is far larger — about 14.8× Medpace Holdings Inc's market cap, and Mitsubishi UFJ Financial Group Inc. Common Stock pays a 2.4% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Mitsubishi UFJ Financial Group Inc. Common Stock for 0 Days on average.
| MEDP | MUFG | |
|---|---|---|
Market Cap | $16.82B | $249.48B |
Volume | 223,093 | 4,008,160 |
Sector | Health | Financials |
52-Week High | $630.19 | $24.13 |
52-Week Low | $393.42 | $14.62 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | $16.44B | $28.96T |
Dividend Yield | — | 2.4% |
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Mitsubishi UFJ Financial Group is a Japanese financial services company providing banking, lending, securities, and asset management services. Its businesses serve individuals, companies, and institutions worldwide.
Read more on MUFG →